Water Soluble Fertilizers Market Research Report and Industry Analysis by 2024

The global water soluble fertilizers market size is expected to reach USD 22.0 billion by 2024, at a registering a CAGR of 6.5% over the forecast period, according to a new report by Grand View Research, Inc. Rising demand for the product as they improve crop quality and increases crop production output significantly will augment market growth over the forecast period. Increasing crop production in countries including China, India, the U.S., Indonesia, Brazil, Japan and Mexico on account of growing population will drive industry size over the next eight years. Decreasing availability of arable land is expected to fuel the product demand over the forecast period.

Horticultural crops are projected to show significant revenue gains at a CAGR of 6.8% from 2016 to 2024 owing to rising consumption of fruits, vegetables, spices and medicinal plants. Moreover, rapid economic development, government support, advancements in fertilizer manufacturing is anticipated to propel market demand.

Further key findings from the report suggest:

• Foliar accounted for 30.4% of the overall volume and will show steady growth in light of rising application in various fruits & vegetables including tomatoes, beans, and melons. However, high cost as compared to fertigation will pose a challenge to its growth.

• Europe accounted for 37.6% of the overall revenue share in 2015 and is expected to witness significant gains in light of rising food security concern owing to growing population along with high export demand for food products including wheat and cereals from Germany, France, Italy and UK. Moreover, the presence of key participants including Yara International, Bunge Ltd., Agrium, Eurochem, Potash Corp, and CF Industries will promote industry growth.

• Latin America will witness substantial revenue rise at a CAGR of 7.2% from 2016 to 2024 on account of the presence of various major participants including The Mosaic Company, Potash Corp, and Haifa Chemicals. Development of agricultural policies and government schemes to promote micro irrigation systems, which dispenses water soluble fertilizers will augment industry size.

• Water soluble fertilizers industry is dominated by major participants including Agrium Inc., Potash Corp, Israel Chemicals Limited, The Mosaic Company, K+S AG, and Yara International ASA. Ongoing product innovation to produce efficient and cost-effective fertilizers is expected to lead to industry expansion over the next eight years.

• In April 2016, Yara International expanded the Rio Grande fertilizer plant capacity in Brazil to create one of the most modern fertilizer sites. In December 2015, Yara International acquired Greenbelt Fertilizers to expand the fertilizer business in Zambia and surrounding areas that were experiencing fast agricultural growth. In March 2015, Israel Chemicals planned to build a potassium nitrate production plant to meet growing demand for soluble specialty fertilizers.

Fertilizer Industry Size was valued at USD 201.3 Million Tons in 2021 and is projected to expand at a CAGR of 1.2% during 2022 to 2030.

Water Soluble Fertilizer Market Segmentation

Grand View Research has segmented the global water soluble fertilizers market on the basis of product, crop type, application, and region:

Water Soluble Fertilizers Product Outlook (Volume, Kilo Tons; Revenue, USD Million, 2013 – 2024)

• Nitrogenous

• Phosphatic

• Potassium

• Micronutrients

• Secondary nutrients

Water Soluble Fertilizers Crop Type Outlook (Volume, Kilo Tons; Revenue, USD Million, 2013 – 2024)

• Field

• Horticultural

• Plantation

• Turf & ornamental

Water Soluble Fertilizers Application Outlook (Volume, Kilo Tons; Revenue, USD Million, 2013 – 2024)

• Fertigation

• Foliar

Water Soluble Fertilizers Regional Outlook (Volume, Kilo Tons; Revenue, USD Million, 2013 – 2024)

• North America

  • U.S.
  • Mexico
  • Canada

• Europe

  • Germany
  • UK
  • Italy
  • Russia
  • Spain
  • Ukraine

• Asia Pacific

  • China
  • India
  • Japan
  • Australia
  • Malaysia

• Latin America

  • Brazil

• MEA

  • South Africa

Request free sample copy of Fertilizer Industry Data Book @ https://www.grandviewresearch.com/sector-report/fertilizer-industry-data-book/request/rs1

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Advertisement

Breast Pumps Market Analysis, Recent Trends and Regional Growth Forecast 2022-2030

The global breast pump market is expected to reach USD 5.20 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to register a CAGR of 8.3% from 2022 to 2030. Improving healthcare infrastructure in emerging economies, increasing global women’s employment rates and the presence of favorable demographics are the key driving factors for the breast pump market.

Moreover, the market has seen significant growth over the last few decades, owing to increasing product launches by key players, and rising R&D activities. For instance, in March 2021, the Philips Avent Double Electric Breast Pump, Advanced is the top brand of mothers and children care goods recommended by pregnant women and mothers in the U. S. It features Natural Action technology, a powerful combination of suction and nipple stimulation that simulates the distinctive wave-like tongue motion that occurs when the baby sucks. This technology initiates the milk flow faster than previous models, enabling moms to express their milk more effectively.

Similarly, in October 2021, Willow also launched its Perfect Pumping Bra, developed by The Dairy Fairy. Willow pump bra was designed to provide moms with exceptional comfort, support, and a perfect fit, helping them to have the best possible pumping experience. The appropriate fit can help boost the mother’s milk flow while using wearable breast pumps. Adjustable straps, a customizable mesh panel, beautiful lace embellishments, and a patent-pending double extender clip characterize the Willow Perfect Pumping Bra. Furthermore, the wire-free bra’s luxurious fabric is machine washable and elastic while still being designed to secure the Willow pump for an ideal pumping experience. As a result, product launches with additional benefits are expected to increase market growth for these breast pumps over the projection period.

Breast Pump Market Report Highlights

• In terms of product, closed system segment held the largest market share of 65.3% in 2021 and is expected to witness the fastest growth over the forecast period due to its several benefits and high adoption, as compared to the open system.

• In terms of technology, electric pumps segment held the largest share in 2021 owing to its flexibility and ease of use.

• In terms of application, hospital grade segment held the largest market share in 2021, owing to the increasing number of hospitals and rising healthcare expenditure.

• North America is expected to dominate the market growth over the forecast period owing to the rising women’s employment and large presence of key players operating in the market.

Breast Pump and Breastfeeding Accessories Market Size was valued at USD 4.06 Billion in 2021 and is projected to expand at a CAGR of 7.8% during 2022 to 2030.

Breast Pump Market Segmentation

Grand View Research has segmented the global breast pump market report on the basis of product, technology, application, and region:

Breast Pump Product Outlook (Revenue, USD Million, 2018 – 2030)

• Open System

• Closed System

Breast Pump Technology Outlook (Revenue, USD Million, 2018 – 2030)

• Manual Pumps

• Battery Powered Pumps

• Electric Pumps

Breast Pump Application Outlook (Revenue, USD Million, 2018 – 2030)

• Personal Use

• Hospital Grade

Breast Pump Regional Outlook (Revenue, USD Million, 2018 – 2030)

• North America

  • U.S.
  • Canada

• Europe

  • U.K.
  • Germany
  • France
  • Italy
  • Spain

• Asia-Pacific

  • Japan
  • China
  • India
  • Australia
  • South Korea

• Latin America

  • Brazil
  • Mexico
  • Argentina
  • Colombia

• MEA

  • South Africa
  • Saudi Arabia
  • UAE

List Of Key Players In Breast Pump Market

• Ameda (Magento, Inc.)

• Hygeia Health

• Medela AG

• Koninklijke Philips N.V.

• Lansinoh Laboratories, Inc.

• Pigeon Corporation

• Motif Medical

• Chiaro Technology Limited (Elvie)

• Willow Innovations, Inc.

• Spectra Baby USA

Request free sample copy of Breast Pump and Breastfeeding Accessories Industry Data Book @ https://www.grandviewresearch.com/sector-report/breast-pump-breastfeeding-accessories-industry-data-book/request/rs1

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

In Vitro Diagnostics Quality Control Market Trends, Growth, Opportunities and Worldwide Forecast By 2026

The global IVD quality control market size is expected to reach USD 1.24 billion by 2026, according to a new report by Grand View Research, Inc. The market is projected to witness a CAGR of 4.1% over the forecast period. Continually evolving technology-oriented changes in the diagnostics field and growing need to ensure patient safety necessitate the implementation of quality assurance programs in various medical disciplines including radiology and Point-of-Care (PoC) devices. Patients rely on self-testing IVD devices for long-term disease management and hence it is important for such devices to be checked, in terms of result reproducibility and validity, to guarantee patient safety.

Rising number of certified clinical laboratories offering dependable IVD-based diagnostic services directly correlates with increased patient confidence, thus driving the market. In addition to quality assessments, amendments to the regulatory framework are made intermittently to enhance the existing standards with the main objective of safeguarding qualitative superiority of the diagnostic services. In May 2016, the European Union passed an agreement to update the pre-existing regulations pertaining to IVD devices, wherein the updates were in concern with raising the patient safety levels, particularly for disabled persons. The presence of third-party agencies for independent assessment of the IVD devices is expected to elevate the current safety standards, which will drive the In Vitro Diagnostics (IVD) Quality Control market further.

Further key findings from the study suggest:

• In 2018, the clinical chemistry was the second-largest application segment of the global IVD market, in terms of market share

• Demand for preventive medicine and rapid transformation of clinical laboratories into highly automated and efficient businesses are some of the factors for the segment’s growth

• Molecular diagnostics is projected to be the fastest-growing segment due to increasing technical complexity of molecular diagnostic testing and need for quality evaluation to ensure standards

• These tests are of prime importance as the outcomes enable healthcare practitioners make critical treatment decisions

• Hospitals was the largest segment in 2018 due to the presence of advanced technology-based devices like Next Generation Sequencing (NGS) and microarrays, and rising applications of the optimized quality-control procedures

• North America was the dominant regional market in 2018 due to the presence of over 150,000 registered diagnostics labs and is likely to maintain the dominance throughout the forecast years

• Siemens Healthcare GmbH; Roche Diagnostics; Alere, Inc.; Abbott Laboratories, Inc.; Qiagen N.V.; Bio-Rad Laboratories, Inc.; Quidel Corp.; Becton, Dickinson and Company; bioMerieux, Inc.; Sysmex Corp.; Sero AS; and Thermo Fisher Scientific, Inc. are some of the key companies in the global market

The global In Vitro Diagnostics (IVD) and IVD quality control market combines to account for USD 112.79 billion in revenue in 2021, which is expected to reach USD 114.73 billion by 2030, growing at a cumulative rate of 0.2% over the forecast period. 

In Vitro Diagnostics Quality Control Market Segmentation:

Grand View Research has segmented the global IVD quality control market on the basis of application, type, end use, and region:

IVD Quality Control Application Outlook (Revenue, USD Million, 2014 – 2026)

• Immunochemistry

• Hematology

• Clinical Chemistry

• Molecular Diagnostics

• Coagulation

• Microbiology

• Others

IVD Quality Control Type Outlook (Revenue, USD Million, 2014 – 2026)

• Quality Control

  • Quality Controls, by Type
  • Plasma-based Control
  • Serum-based Control
  • Whole Blood-based Control
  • Others
  • Quality Controls, by Application
  • Immunochemistry
  • Hematology
  • Clinical Chemistry
  • Molecular Diagnostics
  • Coagulation
  • Microbiology
  • Others

• Quality Assurance Services

  • Immunochemistry
  • Hematology
  • Clinical Chemistry
  • Molecular Diagnostics
  • Coagulation
  • Microbiology
  • Others

• Data Management

  • Clinical Chemistry
  • Immunochemistry
  • Hematology
  • Molecular Diagnostics
  • Coagulation
  • Microbiology
  • Others

IVD Quality Control End Use Outlook (Revenue, USD Million, 2014 – 2026)

• Hospitals

• Laboratories

• Home-care

• Others

IVD Quality Control Regional Outlook (Revenue, USD Million, 2014 – 2026)

• North America

  • U.S.
  • Canada

• Europe

  • U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Russia

• Asia Pacific

  • Japan
  • China
  • India
  • South Korea
  • Singapore
  • Australia

• Latin America

  • Brazil
  • Argentina

• Middle East & Africa

  • South Africa
  • UAE
  • Saudi Arabia

Order a free sample of this Intelligence study @ https://www.grandviewresearch.com/sector-report/in-vitro-diagnostics-ivd-quality-control-industry-data-book/request/rs1 

Worldwide Surge In Women’s Employment Rate Is Expected To Increase The Demand For Wearable Breast Pumps 2022-2030

The global wearable breast pumps market is anticipated to reach USD 975.5 million by 2030, registering a CAGR of 8.21%, according to a new report by Grand View Research, Inc. Favorable reimbursement policies, and increasing patient disposable income are further anticipated to propel the demand for wearable breast pumps.

The decreasing infant mortality rate is supplementing the growth of the market. For instance, according to Knoema, the infant mortality rate in Japan fell from 13.4 deaths per 1,000 births in 1970, to 1.80 deaths in 2019. Similarly, as per Statistics Canada, the infant death rate has fallen from 4.8 per 1,000 in 2018 to 4.5 in 2020 in Canada. Such instances are expected to increase the demand for wearable breast pumps, thereby, propelling the market growth over the forecast period.

Increase in women’s employment rate is expected to be a high impact rendering driver of the market. For instance, as per International Labor Organization, the female working population in Australia has touched 60%. Similarly, as per the similar source, the female employment rate in high income countries is estimated to be 53%, whereas, the same in low income and upper middle-income countries is calculated to be 56% and 55% respectively. Working women have a relatively high disposable income, as a result can help the market impel.

The presence of various e-commerce sites offering wearable breast pumps will further aid in the sales of the products through these sales channels in the forecast period. Willow, Elvie, Medela, and Amazon, are few prominent e-commerce sites that offers substantial discounts, and prompt customer service on various wearable breast pumps, owing to which individuals prefer to shop from online sites.

The decline in the COVID-19 population is anticipated to boost market growth. Recently, many companies have called back their employees to work from office. For instance, companies such as Sun Pharmaceuticals, Biocon, and JP Morgan are planning to start work from office. This will surge the need for wearable breast pumps for working women, thereby propelling the market growth in post-COVID-19 time. Similarly, to cope with the rising demand many companies are launching new products and expanding their geographic presence. For instance, in February 2021, Medela LLC launched a new category expansion and breast care products with an aim of meeting customer requirements. This was expected to expand the customer base of the company.

Wearable Breast Pumps Market Report Highlights

• Based on components, the wearable pumps segment dominated the market with a share of 57.84% in 2021 and is also expected to witness the fastest growth rate owing to its increasing demand over the forecast period. As lactating mothers are becoming more aware of the importance and benefits of breastfeeding.

• On the basis of technology, the battery powered wearable breast pump segment dominated the market with a share of 48.64% in 2021. This can be credited to their lightweight and compact designs. Moreover, women can also easily stash them into their bags and are barely noticeable.

• North America dominated the market with the highest revenue share of 52.62% in 2021 owing to a rise in women’s employment rate in the U.S. and supportive reimbursement policies for wearable breast pumps.

Breast Pump and Breastfeeding Accessories Market Size was valued at USD 4.06 Billion in 2021 and is projected to expand at a CAGR of 7.8% during 2022 to 2030.

Wearable Breast Pumps Market Segmentation
Grand View Research has segmented the global wearable breast pumps market based on component, technology, and region:

Global Wearable Breast Pumps Component Outlook (Revenue, USD Million, 2018 – 2030)

• Wearable Pumps

• Accessories

Global Wearable Breast Pumps Product Technology Outlook (Revenue, USD Million, 2018 – 2030)

• Manual Wearable Breast Pumps

• Battery Operated Wearable Breast Pumps

• Smart Wearable Breast Pumps

Global Wearable Breast Pumps Regional Outlook (Revenue, USD Million, 2018 – 2030)

• North America

  • U.S.
  • Canada

• Europe

  • U.K.
  • Germany
  • France
  • Italy
  • Spain

• Asia Pacific

  • Japan
  • China
  • India
  • Australia
  • South Korea

• Latin America

  • Mexico
  • Brazil
  • Argentina
  • Colombia

• Middle East and Africa (MEA)

  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players in Wearable Breast Pumps Market

• Medela AG

• Ameda, Inc.

• Willow Innovations, Inc.

• Philips

• Elvie (Chiaro Component Ltd)

• Freemie

• BabyBuddha Products, LLC

• Spectra

• iAPOY

• Lavie Mom

Request free sample copy of Breast Pump and Breastfeeding Accessories Industry Data Book @ https://www.grandviewresearch.com/sector-report/breast-pump-breastfeeding-accessories-industry-data-book/request/rs1

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

In Vitro Diagnostics Market Statistical Forecast and Competitive Analysis Report 2022-2030

The global in vitro diagnostics market size is expected to reach USD 113.38 billion by 2030, according to a new report by Grand View Research, Inc. It is estimated to register a CAGR of 0.2% over the forecast period driven by the increasing geriatric population, COVID-19 pandemic, and technological advancements in diagnostics that are supporting its adoption. Technological advancements in terms of portability, accuracy, and cost-effectiveness are projected to be one of the high-impact rendering drivers. Technological advancements were further accelerated by the launch of COVID-19 IVD diagnostics and enhanced the adoption of instruments and consumables for technologies, such as PCR. Competitors in the market are increasingly adopting agreement and partnership strategies to maintain a constant flow of business for manufacturers & diagnostics for users.

These agreements are also a result of the harsh price containment strategies for government laboratories, which lowers the price in government settings. For instance, in April 2021, the Italian subsidiary of Seegene, Inc. received a USD 108.25 million tenders for public procurement for the supply of extraction reagents, as well as 7.15 million SARS-CoV-2 diagnostic tests. However, it increases the multiparty nature and complexity of the supply chain. The high prevalence of cancer and Cardiovascular Diseases (CVDs) globally is anticipated to drive diagnostic innovation to facilitate early diagnosis and meet the constantly evolving needs of consumers. Novel technologies, such as plasmonic PCR, are anticipated to commercially enter the market during the forecast period, influencing the business of existing products adversely.

In Vitro Diagnostics Market Report Highlights

• Molecular diagnostics is anticipated to grow at the fastest CAGR from 2022 to 2030 owing to the rising adoption and usage rate

• Reagents held the largest market share owing to the surge in demand for genetic testing and enhanced availability of technologically advanced diagnostic tests in lower and middle-income countries with unmet clinical needs

• The infectious diseases application segment held the largest market share owing to the large volume of testing for infectious diseases globally

• North America dominated the global market in 2021 owing to the high demand for novel technologies, a large pool of key players, high prevalence of diseases, and advanced healthcare infrastructure

The global In Vitro Diagnostics (IVD) and IVD quality control market combines to account for USD 112.79 billion in revenue in 2021, which is expected to reach USD 114.73 billion by 2030, growing at a cumulative rate of 0.2% over the forecast period. 

In Vitro Diagnostics Market Segmentation

Grand View Research has segmented the global in vitro diagnostics market based on product, technology, application, end-use, test location, and region:

IVD Product Outlook (Number of Instruments Installed in Thousands, Number of Reagents Sold in Millions; Revenue, USD Million, 2018 – 2030)

• Instruments

• Reagents

• Services

IVD Technology Outlook (Number of Instruments Installed in Thousands, Number of Reagents Sold in Millions; Revenue, USD Million, 2018 – 2030)

• Immunoassay

  • Instruments
  • Reagents
  • Services

• Hematology

  • Instruments
  • Reagents
  • Services

• Clinical Chemistry

  • Instruments
  • Reagents
  • Services

• Molecular Diagnostics

  • Instruments
  • Reagents
  • Services

• Coagulation

  • Instruments
  • Reagents
  • Services

• Microbiology

  • Instruments
  • Reagents
  • Services

• Others

  • Instruments
  • Reagents
  • Services

IVD Application Outlook (Revenue, USD Million, 2018 – 2030)

• Infectious Disease

• Diabetes

• Oncology

• Cardiology

• Nephrology

• Autoimmune Disease

• Drug Testing

• Others

IVD End-use Outlook (Number of Instruments Installed in Thousands, Number of Reagents Sold in Millions; Revenue, USD Million, 2018 – 2030)

• Hospitals

• Laboratories

• Home Care

• Others

IVD Test Location Outlook (Revenue, USD Million, 2018 – 2030)

• Point of Care

• Home Care

• Others

IVD Regional Outlook (Number of Instruments Installed in Thousands, Number of Reagents Sold in Millions; Revenue, USD Million, 2018 – 2030)

• North America

  • U.S.
  • Canada

• Europe

  • U.K.
  • Germany
  • Spain
  • France
  • Italy
  • Russia

• Asia Pacific

  • Japan
  • China
  • India
  • South Korea
  • Singapore
  • Australia
  • Latin America
  • Brazil
  • Mexico
  • Argentina

• Middle East and Africa (MEA)

  • South Africa
  • UAE
  • Saudi Arabia

List of Key Players in In Vitro Diagnostics Market

• Abbott

• Bio-Rad Laboratories, Inc.

• Quest Diagnostics

• bioMérieux SA

• QIAGEN

• Sysmex Corp.

• Agilent Technologies

Order a free sample of this Intelligence study @ https://www.grandviewresearch.com/sector-report/in-vitro-diagnostics-ivd-quality-control-industry-data-book/request/rs1 

About Grand View Research 

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Breastfeeding Accessories Market Trends and Their Impact On Global Industry 2022-2030

The global breastfeeding accessories market size is expected to reach USD 3.90 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.45% from 2022 to 2030. An increasing women’s employment rate is expected to surge the demand for breastfeeding accessories, thereby propelling the market growth. For instance, according to the data from the World Bank and the International Labor Organization, 55% of women in the U.S. are employed, whereas this number increases in the U.K. with 59% women employability. Working women are more likely to purchase breastfeeding accessories, thus, with a surge in the women’s employment rate, the market is expected to grow over the forecast period.

Moreover, there has been a rise in the global birth rate. For instance, as per the latest report by the International Institute of Sustainable Development (IISD), the global fertility rate has touched 2.3 births per woman, which is well above the replacement rate. Similarly, there has been an increase in the number of milk banks across the globe. For instance, as per the European Milk Bank Association, there are 280 active milk banks in Europe. Likewise, according to the International Breastfeeding Journal, there were 80 milk banks in India as of 2020. Thus, with the establishment of milk banks globally, the market is anticipated to witness growth during the forecast period.

Furthermore, with the introduction of the COVID-19 vaccine and the lifting of lockdown impositions, the market may witness considerable growth over the forecast period. This can be attributed to the opening of offices globally and the initiation of work from office or hybrid work settings. For instance, Microsoft has given their employees 30 days to shift towards a new pattern of hybrid working setting, which has started from February 2022. Furthermore, many market players are initiating strategies such as product launches, partnerships, collaboration, and awareness campaigns to expand their reach. For instance, various market players such as Medela LLC and Laura & Co. are increasing awareness among the target population by arranging programs and distributing magazines. Thus, the aforementioned factors may help the market grow over the forecast period.

Breastfeeding Accessories Market Report Highlights

• Based on product, the breastmilk storage and feeding segment dominated the market with a share of over 15.0% in 2021 owing to an increase in the women’s employment rate

• The postpartum recovery accessories product segment is expected to register the fastest growth rate over the forecast period. An increase in the number of births is anticipated to have a significant impact on the use of postpartum recovery accessories

• Asia Pacific held the largest revenue share of over 40.0% in 2021 owing to the presence of a large target population and an increase in the birth rate

Breast Pump and Breastfeeding Accessories Market Size was valued at USD 4.06 Billion in 2021 and is projected to expand at a CAGR of 7.8% during 2022 to 2030.

Breastfeeding Accessories Market Segmentation

Grand View Research has segmented the global breastfeeding accessories market on the basis of product and region:

Breastfeeding Accessories Product Outlook (Revenue, USD Million, 2018 – 2030)

• Nipple Care Products

• Breast Shells

• Breast Pads

• Breastmilk Preparation and Cleaning Products

• Breastmilk Storage and Feeding

• Perineal Cooling Pads

• Breast Heating Pads

• Breast Cooling Pads

• Baby Weighing Scales

• Maternity/Nursing Bras

• Nursing Tank Tops

• Lactation Massager

• Breast Pump Carry/Tote Bags

• Postpartum Recovery Accessories


Breastfeeding Accessories Regional Outlook (Revenue, USD Million, 2018 – 2030)

• North America

  • U.S.
  • Canada

• Europe

  • U.K.
  • Germany
  • France
  • Italy
  • Spain

• Asia Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia

• Latin America

  • Brazil
  • Mexico
  • Colombia
  • Argentina

• Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE


List of Key Players in Breastfeeding Accessories Market

• Medela AG

• Ameda, Inc.

• Willow Innovations, Inc.

• Koninklijke Philips N.V.

• Chiaro Technology Limited

• Pigeon Corporation

• Spectra Baby

• Lavie Mom

• Motif Medical

• Mayborn Group Limited

Request free sample copy of Breast Pump and Breastfeeding Accessories Industry Data Book @ https://www.grandviewresearch.com/sector-report/breast-pump-breastfeeding-accessories-industry-data-book/request/rs1

About Grand View Research 

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: https://astra.grandviewresearch.com/

Antiviral Drugs Market Overview And Analysis to 2028

Antiviral Drugs Industry Overview

The global antiviral drugs market size to be valued at USD 60.0 billion by 2028 and is expected to grow at a compound annual growth rate (CAGR) of (-0.6%) during the forecast period. The introduction of the generic version of antiviral medicines and growing awareness about the availability of various vaccines for viral infections is affecting the growth during the forecast period.

However, the increasing prevalence of viral infections such as HIV, Herpes, Influenza, and others are expected to increase the demand for antiviral medicines over the forecast period. For instance, according to UNAIDS, in 2020, more than 37 million individuals were living with HIV across the globe. Out of these, approximately 1.5 million new people acquired HIV infection in 2020. Overall, the COVID-19 pandemic has significantly increased market growth in 2020 whereas, a negative impact of the pandemic has been observed for other applications of antiviral drugs.

Antiviral Drugs Market

The increasing incidence of viral infection across the globe is a major factor driving the demand for antiviral drugs over the forecast period. According to WHO, globally, an estimated 325 million people are living with hepatitis infection and out of these, around 71 million have chronic hepatitis C virus infection. Moreover, the U.S. Department of Health and Human Services has estimated that 2.4 million people are living with hepatitis C in the United States and around 850,000 individuals in the country have hepatitis B infection. An increasing base of patients is anticipated to increase the demand for antiviral drugs globally.

Gather more insights about the market drivers, restrains and growth of the Global Antiviral Drugs Market

Increasing approval and expected commercialization of novel medicines for viral infections are anticipated to drive market growth. For instance, in November 2020, the U.S. FDA has approved a supplemental New Drug Application for Roche’s Xofluza for the treatment of influenza in patients 12 years of age and older. Moreover, the major players in the market have launched many novel medicines in 2 to 3 years for the treatment of viral infections. For instance, Gilead Sciences, Inc. has launched Biktarvy, Symtuza, and Veklury for the treatment of viral infections. Furthermore, GlaxoSmithKline plc. has launched Dovato, Cabenuva, and Juluca for the treatment of diseases caused by the virus. An increase in the introduction of novel products in the market will drive growth over the next 2 to 3 years.

The outbreak of the COVID-19 pandemic has significantly increased the demand for antiviral medicines globally. The treatment of novel coronavirus has increased the demand for broad-spectrum antiviral drugs to manage the disease. Remdesivir, favipiravir, oseltamivir, and other combination medicines are highly prescribed for the treatment of COVID-19. Moreover, governments are increasing funding to pharmaceutical companies to develop novel therapeutics against COVID-19. For instance, in June 2021, the U.S. government has announced an investment of more than USD 3 billion to fasten the discovery, development, and manufacturing of antiviral medicines for COVID-19 treatment. The rising incidence of disease coupled with increasing R&D will increase the demand for antiviral drugs in the next 2 to 3 years.

Increasing collaborations for the development and manufacturing of antiviral drugs are expected to result in the development of a high number of novel drugs in the coming years. The key players in the market are collaborating for the R&D of new therapies to reduce the burden of viral infection treatment. For instance, in 2020, Gilead Sciences, Inc. has signed licensing agreement with pharmaceutical manufacturers such as Cipla Ltd., Hetero Labs Ltd., Dr. Reddy’s Laboratories Ltd., Mylan, and others to expand the supply of remdesivir.

Browse through Grand View Research’s Pharmaceuticals Industry Research Reports.

Immunotherapy Drugs Market: The global immunotherapy drugs market size was valued at USD 110.55 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 6.92% from 2022 to 2030. The market is primarily driven by the rising incidence of chronic diseases globally.

Topical Drugs MarketThe global topical drugs market size was valued at USD 97.42 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 10.1% from 2022 to 2030. The industry growth is primarily driven by the rising incidence of skin disorders and diabetes. According to the British Journal of Dermatology, skin diseases affect almost one-third of the global population.

Antiviral Drugs Market Segmentation

Grand View Research has segmented the global antiviral drugs market on the basis of drug class, type, application, and region:

Antiviral Drug Class Outlook (Revenue, USD Million, 2017 – 2028)

• DNA Polymerase Inhibitors

• Reverse Transcriptase Inhibitors

• Protease Inhibitors

• Neuraminidase Inhibitors

• Others

Antiviral Drugs Type Outlook (Revenue, USD Million, 2017 – 2028)

• Branded

• Generics

Antiviral Drugs Application Outlook (Revenue, USD Million, 2017 – 2028)

• HIV

• Hepatitis

• Herpes

• Influenza

• Others

Antiviral Drugs Regional Outlook (Revenue, USD Million, 2017 – 2028)

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East & Africa

Key Companies profiled:

Some prominent players in the Global Antiviral Drugs Market include

• F. Hoffmann-La Roche Ltd.

• GlaxoSmithKline plc

• AbbVie

• Merck & Co., Inc.

• Johnson & Johnson Services, Inc.

• Bristol-Myers Squibb Company

• Cipla Inc.

• Aurobindo Pharma

• Dr. Reddy’s Laboratories Ltd.

Order a free sample PDF of the Antiviral Drugs Market Intelligence Study, published by Grand View Research. 

Augmented Reality & Virtual Reality In Healthcare Market Survey, Opportunities and Trends to 2028

Augmented Reality & Virtual Reality In Healthcare Industry Overview

The global Augmented Reality & Virtual Reality in healthcare market size was valued at USD 2.0 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 27.2% from 2021 to 2028. 

Technological advancements and digitalization in healthcare, favorable government initiatives, rising healthcare expenditure, growing usage in surgical procedures, and medical training are some of the fundamental factors anticipated to boost the growth and adoption of the augmented reality (AR) and virtual reality (VR) technologies in the healthcare industry. These technologies have wide applications in healthcare including surgeries, diagnostics, rehabilitation, training, and education.

Augmented Reality & Virtual Reality In Healthcare Market

Augmented and virtual reality techniques are being increasingly adopted in surgeries and diagnostics. Systems such as touch surgery use virtual reality to provide a view of the patient’s anatomy and physiology, thereby providing opportunities for surgeons in the operating room, This, in turn, is expected to augment the growth of the market for augmented reality and virtual reality in healthcare. The growing adoption of Augmented Reality (AR) and Virtual Reality (VR) technologies in medical surgeries to optimize surgical procedures and increase the efficiency of treatment is one of the key factors driving market growth over the past few years. For instance, in December 2019, Augmedics launched the Xvision Spine AR guidance system for spine surgeries in the U.S. This solution allows the surgeon to view the 3D spinal anatomy of the patient during the surgery. Augmedics also received the U.S. FDA approval for Xvision in December 2019. Moreover, the increasing practice of storing medical images and patient data on the AR/VR platform helps in reducing requirements for expensive screens and unnecessary staff.

Gather more insights about the market drivers, restrains and growth of the Global Augmented Reality & Virtual Reality In Healthcare Market

Additionally, AR is being widely adopted for education and training purposes for medical personnel. Since AR-based learning modules provide anatomical visualization and simulation it gives the medical personnel a more wholesome complete learning experience. Moreover, these learning modules are even being used to train patients and help them understand the treatment flow and care management better. AR-based image visualization assists the surgeons and enhancing their accuracy and precision during complex surgeries. For instance, in February 2019 Philips Healthcare collaborated with Azurion and Microsoft to develop a mixed reality concept to provide a 3D holographic AR environment derived from multiple image modalities to assist surgeons.

During the outbreak of the COVID-19 pandemic, AR & VR in healthcare was influenced positively owing to the technological advancements in this space. For instance, in April 2020 XRHealth extended its application by raising USD 7 million to expand its telehealth platform. Similarly, Imperial College and St. Mary’s Hospital in London are using augmented reality glasses to visualize 3D imaging of blood vessels during reconstructive surgeries. Augmented reality and virtual reality in healthcare help in efficiently managing the treatment schedules, treatment delivery, and plans, and thereby it is anticipated to exponentially grow during the pandemic. Additionally, the decreasing costs in healthcare, rapid digitalization of healthcare, and improved delivery of effective health services are expected to drive growth. AR and VR in healthcare are gaining momentum due to widespread adoption in telemedicine, medical training & education, patient care management, medical marketing during the COVID-19 pandemic.

Furthermore, mergers and acquisitions, product development and launches, partnerships, and collaborative agreements are some of the crucial initiatives being undertaken by key players, which are expected to propel market growth. For instance, in January 2021 Hologic Inc acquired Biotheranostics, a molecular diagnostics company for USD 230 million. Through this acquisition, Hologic Inc and Biotheranostics will combine their capabilities and utilize their expertise in oncology diagnostics and advanced woman health diagnostics.

Browse through Grand View Research’s Healthcare IT Industry Research Reports.

Oncology Information Systems Market: The global oncology information systems market was valued at USD 2.4 billion in 2021 and is projected to expand at a compound annual growth rate (CAGR) of 7.8% from 2022 to 2030. Monumental growth of healthcare IT, the increasing global prevalence of cancer, increasing expenditure in development around treatment & solutions for cancer care, and increasing adoption of OIS solutions by healthcare facilities is some of the key factors anticipated to drive the growth of the market.

Real World Evidence Solutions MarketThe global real world evidence solutions market size was valued at USD 39.7 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 8.1% from 2022 to 2030. Support from regulatory bodies for using real world evidence (RWE) solutions and an increase in R&D spending are anticipated to boost the market growth. 

Augmented Reality & Virtual Reality In Healthcare Market Segmentation

Grand View Research has segmented the global augmented reality & virtual reality in healthcare market on the basis of component, technology, and region:

AR & VR In Healthcare Component Outlook (Revenue, USD Million, 2016 – 2028)

• Hardware

• Software

• Service

AR & VR In Healthcare Technology Outlook (Revenue, USD Million, 2016 – 2028)

• Augmented Reality

• Virtual Reality

AR & VR In Healthcare Regional Outlook (Revenue, USD Million, 2016 – 2028)

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East & Africa

Key Companies profiled:

Some prominent players in the Global Augmented Reality & Virtual Reality In Healthcare Market include

• CAE

• GE Healthcare

• Koninklijke Philips N.V.

• Intuitive Surgical

• Siemens Ltd

• Eon Reality, Inc

• Layar

• Bioflight VR

• WorldViz

• TheraSim Inc

• Mindmaze

Order a free sample PDF of the Augmented Reality & Virtual Reality In Healthcare Market Intelligence Study, published by Grand View Research. 

Hospital Information System Market Growth Report to 2028

Hospital Information System Industry Overview

The global hospital information system market size was valued at USD 57.1 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 5.9% from 2021 to 2028. 

Rising government initiatives and increasing demand from hospitals to deploy advanced IT solutions for effective operational efficiency are some of the key factors for the increase in the adoption of hospital information systems (HIS). The increasing need to reduce healthcare expenditure due to hospital workflow inefficiencies is expected to increase hospital information systems implementation worldwide. Thus, the growing demand for reduced healthcare costs and effective clinical outcomes is one of the key factors responsible for the adoption of information systems in developed economies and also in emerging economies, such as India, China, the Philippines, and Brazil.

Hospital Information System Market

Developing and developed regions are struggling to achieve high care delivery standards, which are both cost-effective and quality-oriented with minimum medical errors. With the help of HIS, providers are now able to streamline their workflows by offering enhanced patient outcomes about costs through investigational mining of electronic patient records for identifying inherent medical inaccuracies in the system. It enables them to offer cost-effective services to patients while reducing resources wastage. Moreover, increasing penetration of technologically advanced hospital management solutions is also aiding the market growth.

Gather more insights about the market drivers, restrains and growth of the Global Hospital Information System Market

The increased implementation of healthcare IT solutions and services by hospitals to provide enhanced patient care at reduced expenses, coupled with the growing need to upgrade already existing information systems, is likely to be a key driving factor. Moreover, consistent upgrades in healthcare and IT infrastructures along with increased adoption of cloud computing in hospital settings are also contributing significantly to the market growth. Since, healthcare data is subject to stringent regulatory oversight to ensure patient confidentiality, safe and secure storage, user-level authorization, traceability of information, and mitigation of other cybersecurity threats. Thus, hospitals are switching from on-premises deployments to cloud-based information systems to maintain high data security and avoid security breaches.

In addition, the growing adoption of EHR systems among developing economies owing to increased utilization of electronic health records for patient-centric care is expected to significantly boost the market growth over the next few years. EHR emerged as one of the key potential segments in hospital information systems, primarily owing to the rising demand for streamlining electronic healthcare solutions, technological advancements in healthcare information IT, and growing demand for EHR-integrated tools. Also, government initiatives promoting EHR are likely to propel the demand for electronic systems. EHRs offer a range of advantages to hospitals and patients, ultimately leading to increased system productivity and patient satisfaction.

Furthermore, associated benefits with these information systems, such as operational cost-reduction minimized errors in the end-use facility, and increased successful operational outcomes, are expected to propel market growth. Moreover, government initiatives supporting eHealth programs in developed as well as developing regions and incentives promoting information systems implementation in hospital settings in certain countries are further expected to drive the market over the forecast period.

Browse through Grand View Research’s Healthcare IT Industry Research Reports.

5G In Healthcare Market: The global 5G in healthcare market size was valued at USD 34.1 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 34.5% from 2022 to 2030. The global market is driven by the rising adoption of robotic surgery and telehealth.

Women’s Health App Market: The global women’s health app market size was valued at USD 2.7 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 19.45% from 2022 to 2030. The increasing incidence of diseases among women and the high penetration of smartphones is expected to drive the market growth. 

Hospital Information System Market Segmentation

Grand View Research, Inc. has segmented the global hospital information system market report on the basis of type, deployment, component, and region:

Hospital Information System Type Outlook (Revenue, USD Million, 2016 – 2028)

• Electronic health record

• Electronic medical record

• Real-time healthcare

• Patient engagement solution

• Population health management

Hospital Information System Deployment Outlook (Revenue, USD Million, 2016 – 2028)

• Web-based

• On-premises

• Cloud-based

Hospital Information System Component Outlook (Revenue, USD Million, 2016 – 2028)

• Software

• Hardware

• Services

Hospital Information System Regional Outlook (Revenue, USD Million, 2016 – 2028)

• North America

• Europe

• Asia Pacific

• Latin America

• MEA

Key Companies profiled:

Some prominent players in the Global Hospital Information System Market include

• Carestream Health

• Siemens Healthineers

• McKesson Corporation

• Philips Healthcare

• Merge Healthcare Inc. (IBM)

• GE Healthcare

• Cerner Corporation

• Allscripts

• NextGen Healthcare

Order a free sample PDF of the Hospital Information System Market Intelligence Study, published by Grand View Research. 

microRNA Market Survey, Opportunities and Trends to 2028

microRNA Industry Overview

The global microRNA market size was valued at USD 854.6 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 19.8% from 2021 to 2028. 

Key trends that have collectively contributed to market growth over the years include emerging microRNA (miRNA) tools for disease-associated analytical applications, immense traction gained by miRNA target prediction and identification, and persisting wide adoption of the majority of the miRNA tools. Additionally, miRNAs are amongst the most important potential biopharmaceutical candidates that are entering in commercial space for developing potential future medicines.

Biopharmaceutical companies are increasingly engaging in the search for new therapeutic molecules that can act as new drugs which is further driving the market for microRNA. There are several miRNA-based candidates that are under clinical trials such as anti-miR compounds and specific inhibitors for miRNAs which can act as potential therapeutic solutions. Hence, RNA therapeutics is considered a trending investing area that will lead to the development of profitable drugs.

Gather more insights about the market drivers, restrains and growth of the Global microRNA Market

Increasing adoption of microRNA as a biomarker is driving the market. The miRNA biomarkers are of particular focus on genome-wide studies, and data-driven methodology, as they demonstrate high reproducibility and robustness when compared to traditional methods. Hence, they serve as promising candidates for the development of biomarkers. Moreover, the growing interest in liquid biopsies has further led to the increasing importance of miRNAs for biomarker discovery and development.

A steep increase in the research activities exploring the potential of miRNA biomarkers across prognosis, diagnosis, and therapeutics is expected to favor the market expansion in the near future. For instance, in January 2020, researchers explored the possibility of miRNA found in peripheral blood as a biomarker for diagnosing Bipolar II disorder (BD-II) using next-generation sequencing. miRNAs can be a possible noninvasive solution for the diagnosis of other neurodegenerative disorders.

In addition, the technological innovation for improving the sensitivity and selectivity of miRNA detection is further contributing to the growth of the market for microRNA. The newly developed methods for miRNA detection include nanoparticle-based amplification, RCA-based methods, DSN-based methods, LAMP-based methods, and enzyme-free amplification. Similarly, in January 2020, researchers developed a program-based isothermal amplification technique for specific and quantitative digital measurement of miRNA. The advantage of the system is that contamination is reduced by the fact that this system is dependent on the signal amplification process rather than direct replication of the targeted sequence, as it is done using PCR-based approaches.

Browse through Grand View Research’s Biotechnology Industry Research Reports.

Genotyping MarketThe global genotyping market was valued at USD 12.65 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 15.6% from 2022 to 2030. The growth can be attributed to technological advancements, the rising prevalence of cancer & genetic disorders, and increasing R&D funding for precision medicine research. 

Cell Culture Media Market: The global cell culture media market size was valued at USD 3,616.8 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 12.1% from 2022 to 2030. Cell culture media is generally a gel or liquid including compounds required to regulate and support the growth of cells or microorganisms used in the manufacturing of biopharmaceuticals.

microRNA Market Segmentation

Grand View Research has segmented the global microRNA market on the basis of products, services, application, end-use, and region:

microRNA Products Outlook (Revenue, USD Million, 2017 – 2028)

• Instruments

• Consumables

microRNA Services Outlook (Revenue, USD Million, 2017 – 2028)

• Service Type

• By Specimen

microRNA Application Outlook (Revenue, USD Million, 2017 – 2028)

• Cancer

• Infectious Diseases

• Immunological Disorder

• Cardiovascular Disease

• Neurological Disease

• Others

microRNA End-use Outlook (Revenue, USD Million, 2017 – 2028)

• Biotechnology & Pharmaceutical Companies

• Academic & Government Research Institutes

• Other end-users

microRNA Regional Outlook (Revenue, USD Million, 2017 – 2028)

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East & Africa

Key Companies profiled:

Some prominent players in the Global microRNA Market include

• Merck KGaA

• Thermo Fisher Scientific, Inc.

• Horizon Discovery Ltd.

• Synlogic

• QIAGEN

• GeneCopoeia, Inc.

• New England Biolabs

• Quantabio

• NanoString

• BioGenex

• SeqMatic LLC

• Miltenyi Biotec

• Sistemic Scotland Limited

• Biodynamics Laboratory Inc.

• OriGene Technologies, Inc.

Order a free sample PDF of the microRNA Market Intelligence Study, published by Grand View Research.